Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 11Motor Activity 3Osteoporosis 2Neoplasms 2Urinary Incontinence 1Urinary Bladder Neoplasms 1Stroke 1Signs and Symptoms 1Sarcopenia 1Rectal Neoplasms 1Pelvic Floor Disorders 1Obesity 1Neoplasm Metastasis 1Kidney Diseases 1Hypertension 1Heart Failure 1Head and Neck Neoplasms 1Frailty 1Diabetes Mellitus 1Colorectal Neoplasms 1Cardiovascular Diseases 1Carcinoma, Transitional Cell 1Arthritis 1

Interventions

Gemcitabine 157Cisplatin 117pembrolizumab 81Cystectomy 46Nivolumab 42Carboplatin 42Paclitaxel 41Mitomycin 41Docetaxel 39atezolizumab 33Magnetic Resonance Spectroscopy 33Radiotherapy 31durvalumab 30avelumab 26BCG Vaccine 26Specimen Handling 25Cystoscopy 24enfortumab vedotin 23Doxorubicin 23Fluorouracil 20Methotrexate 17Vinblastine 16Standard of Care 15Ipilimumab 14Filgrastim 145-aminolevulinic acid hexyl ester 14Transurethral Resection of Bladder 13Surgical Procedures, Operative 13Sunitinib 13Biopsy 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Resistance Training × Genitourinary × Clear all
NCT04223063 2020-01-10

Exercise-based Pre-habilitation in Bladder Cancer Patients Prior to Radical Cystectomy: a Feasibility Study

Nova Scotia Health Authority

Phase NA Unknown
20 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡